Here are the most interesting items we saw this week in women’s health:
🤰 Tylenol is still safe in pregnancy, whatever the president said. After Trump and RFK Jr. warned against acetaminophen without strong evidence, the Society for Maternal-Fetal Medicine reaffirmed it as the first-line treatment for pain and fever, finding no causal link to autism or ADHD. Two in three pregnant women use it, and untreated first-trimester fever is tied to birth defects and miscarriage.
🩺 Hormone therapy works. Almost no one is taking it. Use among women 40 and older HRT use fell to under 2% by 2023, and just 3.5% of women ages 50 to 59 (the group most likely to benefit), per a Mayo Clinic analysis. The evidence shows it’s safe and effective for many women under 60, and recent changes to “black box” warnings could increase usage.
📊 Real money is finally flowing to midlife health. Melinda French Gates committed $215 million to women’s reproductive and midlife health, her first major bet on perimenopause and menopause. She partnered with the Menopause Society to expand training for the clinicians most women struggle to find.
TOP CLICKED STORIES THIS WEEK
